Status:
COMPLETED
Detection of Colorectal Cancer in Patients With a Positive Fecal Immunochemical Test Using an Electronic Nose Device (AeoNoseTM)
Lead Sponsor:
Radboud University Medical Center
Conditions:
Colorectal Cancer
Polyps of Colon
Eligibility:
All Genders
55-75 years
Phase:
NA
Brief Summary
The present study aims to investigate the diagnostic accuracy of exhaled breath analysis with the Aeonose (the eNose Company, Zutphen, the Netherlands) to distinguish the breath of patients suspected ...
Detailed Description
Study rationale: Colonoscopy plays a key role in all colorectal cancer (CRC) screening modalities. An important limitation of colonoscopy remains that the diagnostic accuracy and therapeutic safety o...
Eligibility Criteria
Inclusion
- Adult patients between the ages of 55 and 75 years referred for a colonoscopy procedures after a positive FIT test.
Exclusion
- Patients with a history of any type of malignancy (not including basal-cell skin cancer (BCC) and squamous-cell skin cancer (SCC))
- Prior surgical resection of any portion of the colon
- Patients who are unable to perform breathing maneuver needed for Aeonose-analysis of exhaled air
Key Trial Info
Start Date :
November 9 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2019
Estimated Enrollment :
3345 Patients enrolled
Trial Details
Trial ID
NCT03346005
Start Date
November 9 2017
End Date
December 31 2019
Last Update
March 16 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Radboud University hospital
Nijmegen, Gelderland, Netherlands, 6525